Paragraph 15
The provisions of this Part are standard provisions of a manufacturer's licence relating to the import of medicinal products F1from—
in the case of an import into Great Britain, a country other than Northern Ireland or a country other than an approved country for import, or
in the case of an import into Northern Ireland, a country other than an EEA State.
Annotations
Textual amendments
- F1
Sch. 4 para. 15(a)(b) substituted for words in Sch. 4 para. 15 (31.12.2020) by S.I. 2019/775, reg. 20(4) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 14(d))
Notes on Part 2
Textual amendments
- F1
Words in Sch. 4 Pt. 2 heading inserted (31.12.2020) by S.I. 2019/775, regs. 1, 20(3) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 14(c))